Hepion Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HEPA and other ETFs, options, and stocks.About HEPA
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease.
CEOJohn T. Cavan
CEOJohn T. Cavan
Employees25
Employees25
HeadquartersEdison, New Jersey
HeadquartersEdison, New Jersey
Founded2013
Founded2013
Employees25
Employees25
HEPA Key Statistics
Market cap9.46M
Market cap9.46M
Price-Earnings ratio-0.17
Price-Earnings ratio-0.17
Dividend yield—
Dividend yield—
Average volume50.76K
Average volume50.76K
High today—
High today—
Low today—
Low today—
Open price$2.07
Open price$2.07
Volume0.00
Volume0.00
52 Week high$20.66
52 Week high$20.66
52 Week low$1.49
52 Week low$1.49